| Combination therapy in combating cancer RB Mokhtari, TS Homayouni, N Baluch, E Morgatskaya, S Kumar, B Das, ... Oncotarget 8 (23), 38022, 2017 | 1902 | 2017 |
| The role of Sulforaphane in cancer chemoprevention and health benefits: A mini-review R Bayat Mokhtari, N Baluch, TS Homayouni, E Morgatskaya, S Kumar, ... Journal of cell communication and signaling 12, 91-101, 2018 | 139 | 2018 |
| Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma R Bayat Mokhtari, N Baluch, M Ka Hon Tsui, S Kumar, T S. Homayouni, ... BMC cancer 17, 1-23, 2017 | 38 | 2017 |
| H. 409 Yeger RB Mokhtari, TS Homayouni, N Baluch, E Morgatskaya, S Kumar, B Das Combination therapy in combating cancer, Oncotarget 8, 38022-38043, 2017 | 26 | 2017 |
| Combination therapy in combating cancer. Oncotarget. 2017; 8 (23): 38022–43 R Bayat Mokhtari, TS Homayouni, N Baluch, E Morgatskaya, S Kumar, ... Epub 2017/04/15. https://doi. org/10. 18632/oncotarget. 16723 PMID: 28410237, 0 | 19 | |
| Combination therapy in combating cancer. Oncotarget. 2017; 8 (23): 38022–43 RB Mokhtari, TS Homayouni, N Baluch, E Morgatskaya, S Kumar, B Das, ... | 18 | |
| Combination therapy in combating cancer. Oncotarget 8 (23): 38022–38043 R Bayat Mokhtari, TS Homayouni, N Baluch, E Morgatskaya, S Kumar, ... | 17 | 2017 |
| Combination therapy in combating cancer. Oncotarget. 2017; 8: 38022–43 R Bayat Mokhtari, TS Homayouni, N Baluch, E Morgatskaya, S Kumar, ... PUBMED, 0 | 14 | |
| Combination therapy in combating cancer. Oncotarget 8, 38022–38043 R Bayat Mokhtari, TS Homayouni, N Baluch, E Morgatskaya, S Kumar, ... | 12 | 2017 |
| Combination therapy in combating cancer. Oncotarget. 2017; 8: 38022–38043 R Bayat Mokhtari, TS Homayouni, N Baluch, E Morgatskaya, S Kumar, ... | 12 | |
| Dual Inhibitors Targeting DNA and Histone Deacetylases C Chen, X Yang, X Hou, H Fang Pharmaceutical Fronts 2 (02), e88-e93, 2020 | | 2020 |
| Abstract B48: Cancer Stem Cells: characteristics, roles in metastatic disease and targeting therapy for the medically underserved Z Morgatskaya, RB Mokhtari, A Tyker, P Kazemi, T Homayouni, N Baluch, ... Cancer Epidemiology, Biomarkers & Prevention 26 (2_Supplement), B48-B48, 2017 | | 2017 |
| Abstract B47: Combating cancer with combination therapy in underserved populations T Homayouni, RB Mokhtari, A Tyker, P Kazemi, Z Morgatskaya, N Baluch, ... Cancer Epidemiology, Biomarkers & Prevention 26 (2_Supplement), B47-B47, 2017 | | 2017 |
| Abstract C28: The combination of Acetazolamide and Sulforophane targets the tumor initiating cells in human bronchial carcinoids N Baluch, R Bayat Mokhtari, T Homayouni, P Akbari, F Heshmati, ... Molecular Cancer Therapeutics 14 (12_Supplement_2), C28-C28, 2015 | | 2015 |
